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ABSTRACT 
Osteoporosis affects millions of people, especially the aged population and numerous researchers focus on developing 
novel pharmacotherapeutic agents for the prevention and treatment of osteoporosis. Animal models have become an 
indispensable part of the preclinical assessment of osteoporotic therapeutics and rat models have been widely preferred. 
Majority of studies so far reported have used young or short-term induced rat models, but they do not mimic the 
pathological condition in senile osteoporosis. Hence this study has focused on developing an ovariectomised and long 
term induced (OLI) aged rat model for the preclinical assessment studies. Long term osteoporosis was induced in 
Wistar rats by ovariectomy followed by the maintenance period of 10 months. Histological evaluation and Micro-CT 
analysis have substantiated the extensive bone loss in the OLI rats compared to Control, ovariectomised and short term 
induced (OSI) rat model. OLI rats also exhibited impairment in the healing of 3 x 1.5 mm femoral cortical bone defect 
even after 8 weeks of surgery. Histomorphometric analysis indicated that OLI rats exhibited a poor regeneration 
efficiency (RE) ratio of 0.67 ± 0.2 compared to 0.95 ± 0.1 in the Control group. Chronic bone loss in the OLI rats 
together with the impaired osteogenic efficacy has been successfully demonstrated which proposes OLI rat models to 
be utilized for investigating novel pharmacotherapies or novel biomaterials intended for osteoporotic applications.   
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Osteoporosis has become a common skeletal 
disease and usually makes its appearance during the late 
age 
1
. At 50 years of age, 4 in 10 women succumb to 
osteoporosis related fractures and a prior fracture 
increases further fracture incidence by 10 fold, thus 
making osteoporotic treatment among the aged 
population an orthopaedic challenge
2
. The alleviating 
number in the elderly population with associated 
osteoporotic fracture incidence has raised much socio 
economic concerns too
3
.  New treatment strategies are 
therefore required to reduce and prevent the onset of 
disease and thereby incidence of fractures.  
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An appropriate animal model is indispensable 
for evaluating the safety and efficacy of any new 
modality prior to its clinical application. Rat 
osteoporotic model has been considered the optimal 
model for osteoporosis research, as it resembles human 
pathological condition in skeletal responses to depletion 
of estrogen and pharmacological effects on bone turn-
over
4
. There are various methods of inducing 
osteoporosis in rats such as ovariectomy, low calcium 
diet and immobilization 
5
. Aging predisposes the 
skeleton to excessive bone loss in conditions of senile 
osteoporosis. Senile osteoporosis is associated with 
progressive changes in bone remodelling, mainly by 
decreasing bone formation relative to bone resorption 
6
. 
However literature review suggests that most animal 
model-based osteoporosis research has been carried out 
in osteoporotic models induced by ovariectomy in 
young rats or by short term induction period of 3-6 
months. Significant age-related changes were not 
observed in bone mineral content (BMC) and bone 
mineral density (BMD) in Sham and ovariectomised rats 
posts 3-6 months of induction
7
. Kubo  et al., has also 
reported the weak effect of short term induced 
osteoporosis (30 weeks post ovariectomy) in the 
mechanical properties and in early phases of bone defect 
healing 
8
. A more appropriate osteoporotic model would 
be to have long term osteoporosis induced animals, so as 
to better mimic the chronic bone loss of the aged human 
clinical pathology. Hence our objective was to develop a 
novel model with chronic bone loss induced by 
ovariectomy followed by a prolonged induction period. 
It was also of interest to evaluate the effect of long term 
induction on the bone healing efficacy in the OLI 
model.  
2. MATERIALS AND METHODS:  
 Ethical statement: 
All in vivo studies were performed as per the 
guidelines and recommendations of the Committee for 
the Purpose of Control and Supervision of Experiments 
on Animals (CPCSEA), India and with the approval of 
the  Institute Animal Ethics Committee (IAEC, India).  
Animals were housed in individually ventilated 
cages at 22±2°C and 55±10% relative humidity (RH). 
Light levels measured (at 1 meter high) less than 300 lx, 
and a 12:12 hour dark/light pattern was maintained. 
Animals were fed with standard pelleted rat feed and 
drinking water ad libitum. The health of the animal 
colony was monitored as per Federation for Laboratory 
Animal Science Associations (FELASA) guidelines for 
parasitology
9
, a written protocol developed from 
international recommendations for bacteriology, 
protozoology and virology and was stamped negative 
for infectious agents. The study also followed the 
Animal Research Reporting of Experiments (ARRIVE) 
guidelines for the execution, evaluation and reporting of 
the in vivo experiments 
10
.  
   
 
Figure 1: Rat model: (A) and (B) Control rat and ovariectomised and long term induced   (OLI) model.  
 
2.1. Bilateral ovariectomy: 
Osteoporosis was induced in female Wistar 
rats - Sctb: WI rats (n=9) (outbred Wistar rats) aged 
3 months, weighing approximately 200 g, by 
bilateral ovariectomy. Animals were further grouped 
as: ovariectomised and short term induced (four 
months, n=3) (OSI), and ovariectomised and long 
term induced (ten months, n=6) (OLI).  Animals 
aged 13 months were included within the Control 
group (n=6) (figure 1A). Surgeries were performed 
under general anesthesia using 80 mg/kg ketamine 
(Anket, Neon Lab, India) and 5 mg/kg xylazine 
(Xylaxin, Neon Lab, India). Briefly, the surgical site 
was clipped and prepared with 5% Povidone iodine 
solution (Betadine, Win Media care, India). The skin 
and abdominal musculature of the abdominal wall 
were incised at the flank level. Using a pair of fine 
tweezers, the peritoneal fat pad was grasped and 
exteriorized to view the ovary and uterine horn on 
each side. The vascular supply to the ovary was 
clamped using mosquito forceps and the ovary was 
excised. After clamping the distal region of the 
uterine horn, a portion of the uterine horn was also 
excised. The clamps were removed and haemostasis 
was confirmed. The tissue and fat pad were replaced 
within the peritoneal cavity using the blunt end of 
vascular forceps and the skin was closed using 3-0 
braided silk (Mersilk, Johnson & Johnson, USA)  in 
a simple interrupted pattern. Povidone iodine 
solution was applied daily for 7 postoperative days 
until the sutures were removed. Post operatively 
animals received subcutaneous injections of 
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Analgesic-Meloxicam (Melonex, Indian 
Immunologicals Ltd, India) at 1mg/kg S/C once 
daily and Buprenorphine (Buprigesic, Neon Lab, 
India) at 0.05 mg/Kg i/m twice daily for 7 days.  
Good nursing support was provided along 
with the medications, by providing a soft and 
absorbent bedding to prevent postsurgical infection. 
Rats were also provided with pre-moistened feed 
pellets for the first three days after surgery and then 
high-quality feed (such as sprouted Bengal gram) 
was provided as soon as the animals recovered, to 
prevent weight loss and to support their high 
nutritional demands. Ovariectomised rats were 
further maintained for 4 months and 10 months to 
develop OSI and OLI groups respectively (figure 
1B).  
2.2 Osteoporotic model assessment:  
2.2.1. Serum Calcium level analysis: 
Serum was isolated from Control, OSI and 
OLI rats (n = 3 each) at 0, 4 and 10 months 
following ovariectomy. Serum Calcium 
concentrations were measured using the kit Arsenazo 
III method (Cat No: BLT0001 Erba, Germany). 
Calcium concentration was then compared between 
the induced and age matched Control groups.  
2.2.2. Micro CT evaluation: 
 Animals (n=3 each from OSI and OLI group) 
were euthanized at 4 and 10 months respectively, 
following osteoporosis induction and proximal tibiae 
were extracted. Muscle tissue was gently scraped off 
and bones were fixed in 10% neutral buffered 
formalin. Metaphyseal cancellous bone at the 
proximal tibiae from Control, OSI and OLI groups 
were scanned using micro CT desktop scanner CT 40 
(Scanco Medical AG, Switzerland) set at 70kVp and 
114µA. A region of interest (ROI) was chosen by 
selective contouring of the trabecular bone image 
slices and three dimensional volumetric model 
reconstructions were performed using in built 
software (version - 6.5). Bone parameters such as 
trabecular number (Tb.N.), trabecular spacing 
(Tb.Sp.) and bone density were assessed and further 
evaluated.  
2.2.3. Histological evaluation: 
For histological analysis formalin fixed 
bone samples (n=3) were decalcified using 12% 
Ethylene di-amine tetra acetic acid (EDTA) and 
underwent a series of dehydration processes in 
alcohol prior to paraffin embedding. Sections from 
the paraffin embedded blocks were cut using a rotary 
microtome (Leica RM 2255, Germany), stained 
using Hematoxylin and Eosin (H&E) and evaluated 
by light microscopy (Leica DM 6000, Germany).  
2.3. Evaluation of effect of long term osteoporosis 
induction in the OLI model:  
2.3.1. Surgical procedure:  
To assess the effect of long term 
osteoporosis induction on bone healing, femoral 
bone defects of 3mm x 1.5mm were made in OLI 
rats (n = 3 rats) and compared with that of the 
Control animals. Under Xylazine-Ketamine 
anaesthesia (5mg/Kg and 80mg/kg, respectively) 
distal femur was exposed through a lateral approach 
and a bone defect was created with a surgical drill 
(Marathon, Saeyang microtech, Korea). The muscle 
flap was then replaced and incision was sutured.   
Postoperatively, all animals received 
antibiotic injections intramuscularly for 7 days. 
Animals also received subcutaneous injections of 
Meloxicam (Melonex, Indian Immunologicals Ltd, 
India) at 1mg/kg S/C once daily and Buprenorphine 
(Buprigesic, Neon Lab, India) at 0.05 mg/Kg I/M 
twice daily. 
2.3.2. Histological evaluation of bone defect 
healing: 
Animals were euthanized 8 weeks post 
surgery and the defect sites, along with the adjacent 
bone, were extracted without disturbing the defect 
area. Retrieved bone samples were then formalin-
fixed and underwent a series of dehydration steps in 
alcohol, followed by infiltration and embedding in 
methyl methacrylate (MMA). Plastic embedded 
blocks were then sectioned using a high-speed 
precision saw (Isomet TM 2000 Precision Saw, 
Buehler, USA). Plastic sections were then manually 
polished down to 70-90 microns using a variable 
speed grinder/polisher (Ecomet 3000, Buehler, USA) 
and stained with Stevenal’s blue and van Gieson’s 
picrofuchsin 
11
. Histological sections were then 
micrographed using the light microscope (Leica DM 
6000, Germany).  
Histomorphometry was performed to 
quantify bone defect healing in the Control and OLI 
animals. Consecutive histological sections (n = 3-4 
plastic sections) from randomly selected blocks were 
blindly evaluated using histomorphometry image 
analyzing software (Leica Qwin, Germany).   
Regeneration ratio (RE) (ratio of New Bone formed 
per Total area: [NB/TA]) was calculated from each 
section to assess the healing efficacy.  
2.4. Statistical analysis: 
All data included in the study were 
expressed as mean ± standard deviation (SD). 
Results of the biochemical analyses of serum 
Calcium concentration and estimation of trabecular 
bone loss based on micro CT scans were evaluated 
using 2 way ANOVA (with multiple comparisons) in 
Graph pad prism (version 6.01). Statistical 
comparisons of histomorphometric data were 
performed using unpaired t tests. A p-value ˂ 0.05 
was considered statistically significant in all analysis.  
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3. RESULTS: 
3.1. Osteoporotic model evaluation:  
 All animals (Control, OSI and OLI) recovered 
from surgery without any adverse effect or 
inflammatory responses.  
3.1.1. Evaluation of serum Calcium 
concentration: 
 
Figure 2: Biochemical analysis: Graphical 
representation of Calcium concentration in the serum 
of the osteoporosis induced rat model post 0, 4 and 
10 months of induction compared to age matched 
Control group. (*- significant, actual p value– 
0.0218).  
Biochemical analyses (figure 2) indicated 
that serum Calcium concentration in ovariectomised 
rats was not significantly different from that of the 
age matched Control group at 0 and 4 months, 
indicating not much bone loss with short term 
induction period. Control group rats exhibited a 
Calcium concentration of 10.91±1.76 mg/dl and 
9.632±0.76 mg/dl, whereas the induced group 
animals exhibited a Calcium concentration of 
10.35±0.3 mg/dl and 10.41±0.74 mg/dl at 0 and 4 
months respectively. The induced rats exhibited a 
Calcium concentration of 16.77±.30 mg/dl post 10 
months of induction, which was significantly higher 
than that of aged matched Control rats, which 
exhibited a Calcium concentration of 13.94±.90 
mg/dl (p value – 0.0218), indicating extensive bone 
loss. 
 
3.1.2. Evaluation of bone loss using micro CT:  
 
Figure 3: Osteoporotic model evaluation using micro CT scans: (A)-(C) depict the 3D trabecular thickness profile of the proximal 
tibial metaphysis from Control, OSI and OLI groups. Thinner trabeculae with less trabecular bone volume were evident in OSI and 
OLI groups. But extensive trabecular disruption was evident in the OLI group. (Color coding represents trabecular thickness - 
thickness increases from green to red).(D), (E) and (F) depict random 2D slices from Control , OSI and OLI groups indicating the 
extent of trabecular bone disruption in OLI rats, when compared to Control and OSI rats.  
 
In Control and OSI rats, trabecular bone (represented 
in greenish yellow color) was seen more prominent 
and extended downwards from the tibial plateau 
(figure 3A and 3B respectively). In the OLI rats, 
trabecular bone was evident only at the proximal tibial 
plateau, indicative of extensive trabecular disruption 
and bone loss. Random 2D slices generated from 
micro CT scans also depicted the extent of trabecular 
disruption among the different groups. In the OSI rat 
model (figure 3E) trabecular network was evident with 
slight disruption compared to a mesh-like network in 
the Control group (figure 3D), whereas in the OLI rat 
model (figure 3F) a few sprouts of trabecular network 
was only evident indicative of excessive bone loss 
compared to other groups.  
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Figure 4: Quantitative evaluation of bone loss using micro CT scans: Decrease in trabecular number (Tb.N.) in the proximal tibial 
region from Control, OSI and OLI groups are represented in (A). Increase in trabecular spacing (Tb.Sp.) in the proximal tibial region 
of OLI group, compared to Control and OSI groups is depicted in (B). Figure 4C indicate the decline in bone density (mg HA/cm3) 
in the OLI and OSI groups, but more significant change was evident in the OLI group, thereby confirming the significance of long 
term induction period in rats. (Fig A – Control vs. OSI **** p value ˂0.0001, Control vs. OLI **** p value ˂0.0001; fig B - Control 
vs. OSI *** p value 0.0002, Control vs. OLI **** p value ˂0.0001; fig C - Control vs. OSI * p value 0.0362, Control vs. OLI ** p 
value ˂0.0051) 
 
Micro CT evaluation (figure 4A) indicated OSI 
and OLI rats to have a trabecular number (Tb.N.) of 
1.73±.17/mm (****p value ˂.0001) and 1.26±.04/mm 
(****p value ˂.0001) respectively, compared to Control 
rats with Tb.N. of 3.65±.01/mm. Significant decline in 
Tb.N. was noted in the osteoporosis induced groups. 
Trabecular Spacing (Tb.Sp.) (figure 4B) was found to be 
0.88±.03mm (****p value ˂.0001) for OLI rats and 
0.62±.02mm (***p value 0.0002) for OSI rats, compared 
to Control rats with Tb.Sp value of 0.27±.003mm. 
Trabecular spacing seemed to increase with advancing 
induction period and significant high value in the OLI 
rats indicate that trabecular bone in the tibial head has 
been almost replaced with void spaces indicating 
trabecular disruption. Evaluation of trabecular bone 
density (figure 4C) also indicated a highly significant 
bone loss in the OLI animals, compared to other groups. 
OLI rats exhibited a significantly low mean density of 
223.2±6.5 mg HA/cm
3
 (**p value 0.0051) whereas the 
OSI rats and Control rats exhibited a value of 
261.82±38.21 mg HA/cm
3
 (*p value 0.0362) and 
331.1±14.54 mg HA/cm
3
. Trabecular bone parameters 
indicated chronic bone loss in the OLI animals, 
compared to OSI and Control rats.  
 
3.1.3. Histological evaluation of trabecular bone loss: 
 
Figure 5: Histological evaluation of bone loss. H&E-stained proximal tibial sections of OSI (A) and OLI rats (B) depict trabecular 
bone disruption. More void spaces with less trabeculae were evident in the OLI group. (Scale bar equivalent to 100µm).  
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Histological evaluation of H&E stained 
sections of the tibial bone depicted a prominent 
trabecular network in the OSI group animals (figure 
5A), whereas, in the OLI animals the trabecular 
network was noticeably thinner and surrounded by 




3.2. Histological evaluation of bone defect healing: 
 
Figure 6: Histological evaluation of bone defect healing: (A) & (B) shows  Stevenal’s blue and van Gieson’s picrofuchsin stained 
plastic sections depicting in vivo healing in Control and OLI rats, 8 weeks after surgery. Large void spaces in the defect area (defect 
area – framed in red box) in the OLI rats (B) indicates delayed bone healing. In Control rats (A) the defect area was almost bridged 
by de novo osteoid matrix.  Histomorphometry analysis (C) in terms of regeneration efficiency ratio indicated impaired healing in 
OLI animals, compared to Control group. (HB – Host Bone, NB – New Bone, VS – Void Space, TA – Total Area, RE – 
Regeneration Efficiency = New Bone/Total Area). ((A) & (B) scale bar equivalent to 200µm. (C) - *** significant, p value 0.0003) 
  
Histological evaluation carried out at eight 
weeks indicated reduced bone regeneration efficiency in 
OLI rats. In Control group (figure 6A), the bone defect 
area was almost bridged and filled with de novo osseous 
tissue. But in the OLI group, (figure 6B) even after eight 
weeks of surgery cortical bridging and closure of the 
defect area was not evident.  Loosely arranged 
osteocytes (immature bone organization) could be 
distinguished in the de novo bone matrix in the control 
animals. But more void spaces with scarce new bone 
formation were evident in the OLI rats, indicative of 
poor healing. Further, histomorphometric analyses (fig 
6C) indicated that OLI rats had a significantly lower RE 
ratio (0.67±.02) compared to age-matched Control 
animals ((RE ratio of 0.95±.0; p = 0.0003), further 
supporting the effect of long term induction period in 
bone healing.  
DISCUSSION: 
The effect of long-term estrogen deficiency in 
rat models, to better mimic the clinical situation of 
senile osteoporosis in postmenopausal women, has not 
been explored. Most in vivo studies employ a short term 
period (3-4 months) of estrogen deficiency in rats for 
osteoporotic induction 
12, 13
 and different outcomes have 
been reported. Aging affects bone quality and has a 
major influence on skeletal morbidity and mobility 
14
. 
Literature suggest that young rat skeletons are not to be 
considered as an appropriate model for senile 
osteoporosis, as bone turnover in these animals is 
primarily modelling (bone formation and bone 
resorption at specific sites), whereas in human 
osteoporosis, bone turnover is considered to be 
remodelling (formation and resorption occur in a cyclic 
manner at the same site) 
15
. However, rat skeletal 
homeostasis is predicted to exhibit a gradual transition 
from modelling to remodelling with aging suggesting 
aged rat models to better mimic clinical pathology 
16
. 
Therefore research on therapeutic modalities should 
consider the bone site and age of the rat model to be 
used. Rats at 6 months old inhibit rapid and linear bone 
growth as a sign of attaining maturity and maintaining 
Calcium haemostasis 
17
. Fukuda and Iida (2004) have 
predicted 12 months old Wistar rats to exhibit age 
related bone loss in the proximal tibial metaphysis 
18
. 
Accordingly, the significantly increased serum Calcium 
level in the 10 months osteoporosis induced OLI 
animals compared to SLI animals suggest the 
significance of long term induction period in view of 
Sunitha et al                                                                                                           Journal of Drug Delivery & Therapeutics. 2017; 7(2):36-43                                      
ISSN: 2250-1177                                                                               [42]                                                                        CODEN (USA): JDDTAO 
clinical senile pathology. An increase in serum calcium 
concentration in normal  rats at 13 months age has been 
reported elsewhere, indicating the effect of aging in 
bone loss 
19, 20
. The OLI models used in the study may 
be considered to have the etiological factors associated 
with estrogen deficiency and aging as the experimental 
animals were 13 months old, post 10 months of 
osteoporosis induction.   
Osteoporosis is reported to mainly affect the 
areas where bone remodelling is higher 
21
, such as the 
proximal tibial metaphysis. Histological sections of 
proximal tibiae of OLI rats exhibited a prominent 
disruption in the trabecular bone, indicating that 
ovariectomy was successful. Qualitative and 
quantitative parameters measured using micro CT 
further substantiated the bone loss. Pathology of 
osteoporosis in humans is characterised by a reduction 
in the trabecular number and an increase in the 
trabecular separation 
22
. Most of the animal models 
reviewed, exhibited similar trends in trabecular micro-
architecture and demonstrated trabecular bone loss 
23
. 
Both OSI and OLI rats exhibited a significant bone loss 
compared to Control animals, but it was well evident 
that the extent of bone loss increased with an increase of 
induction period in the OLI rats. Bone density was 
significantly reduced in the OLI rats supporting the 
hypothesis of long term osteoporosis induction and bone 
loss.  
Meyer et al. reported that prolonged 
osteoporosis significantly impairs the process of fracture 
healing 
24
. In ovariectomised rats, alteration in the 
expression of cytokines and growth factors occurs, 
which eventually alters the mineral matrix composition 
of the bone leading to impaired bone healing 
25
. 
Osteoinductive capacity of bone matrix also decreases 
with age 
27
. Plastic embedded bone sections stained with 
Stevenal’s blue and van Gieson’s picrofuchsin depicted 
impaired healing ability in the OLI model as the de novo 
bone formed within the defect area exhibited a loose 
arrangement of the osteoid matrix, resembling islands of 
woven bone 
28
 with large void space in between and 
scarce cellular infiltration. Oliver  et al., 2013 has also 
reported the significance of using a long term estrogen-
deficient rat model for understanding the 
pathophysiology of osteoporotic fracture healing in an 
open fracture model 
26
. 
Impaired proliferation and differentiation 
potential of resident mesenchymal stem cells and 
induction factors have been reported to delay bone 
healing 
29
. In short term-induced models, delay in 
fracture healing is attributed to the accelerated 
resorption by osteoclast cells resulting in bone loss, but 
these models lack the reduction in osteogenic capacity 
of the bone-forming cells
30
. Conversely, in our study 
impaired osteogenic potential was evident in the long 
term induced osteoporotic model by 8 weeks, whereas 
the Control rats exhibited a complete bridging of the 
defect. Conclusive statements regarding the effect of 
aging on the OLI model can be made by conducting a 
more extensive study including extended time points 
and evaluating exclusive age related parameters. More 
information on the effect of long term induction on the 
mechanical parameters and molecular pathways may 
help in better validating the model for preclinical 
evaluations and further research is warranted.   
CONCLUSION 
The results of the study show that a long term 
osteoporosis induction period following ovariectomy in 
rats, induces chronic bone loss. This is attributed to the 
combined effect of ovariectomy and aging, thus 
mimicking the clinical pathology that exists among the 
geriatric population. The OLI models also exhibited a 
delayed healing pathology, further validating the 
osteoporotic model. Such OLI models may be used in 
future studies to assess the safety and efficacy of drugs 
indented for the prevention and treatment of 
osteoporosis. OLI rat models with inherent delayed 
healing ability may also be suitable for evaluating the in 
vivo osteogenic efficacy of therapeutic implants for 
addressing osteoporotic skeletal reconstructive 
surgeries.   
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